Clinical Trial Update: Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating Buparid/PARI SINUS vs Budes Nasal Spray for chronic rhinosinusitis with nasal polyposis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyposis

Drugs mentioned

• Budes nasal spray
• Buparid (Buparid)
• PARI SINUS

Snippet

Sponsor: Pari Pharma GmbH | Conditions: Rhinosinusitis, Chronic Polyposis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-04-12